How many institutions held AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share in Q4 2024?

23 institutional investors reported AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share for Q4 2024. Use the holders table for investor-level position and value details.

Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD)

Q: What does CUSIP 00808Y406 represent in this 13F holders report?

CUSIP 00808Y406 is the security identifier for AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 00808Y406

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Common Stock, $0.001 par value per share
Total 13F shares: 1,607,038
Total 13F value: $1,382,062
Share change: +1,200,638
SEC-reported price per share: $0.86
Number of holders: 23
Value change: +$1,048,708
Number of buys: 11
Number of sells: 6
Shares outstanding: 1,651,503

Security key

00808Y406

Report period

Q4 2024

Institutions

Top holders

AEMD full security history Ownership snapshot Full 13F holder table AETHLON MEDICAL INC SEC filings AETHLON MEDICAL INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

UBS Group AG

Disclosed value leader

UBS Group AG

Comparable rows

15/15

Latest evidence

30 Sep 2024

13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

UBS Group AG leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens UBS Group AG's linked filing trail.

Comparable ownership Top 5

UBS Group AG 13%

GEODE CAPITAL MANAGEMENT, LLC 6%

VANGUARD GROUP INC 1.3%

Baader Bank Aktiengesellschaft 1%

TWO SIGMA INVESTMENTS, LP 0.93%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
UBS Group AG	13F Company 13F	13%	$101,705 218,253 shares	—	30 Sep 2024
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	6%	$45,890 98,394 shares	—	30 Sep 2024
VANGUARD GROUP INC	13F Company 13F	1.3%	$9,893 21,230 shares	—	30 Sep 2024
Baader Bank Aktiengesellschaft	13F Company 13F	1%	$5,790 17,329 shares	—	30 Sep 2024
TWO SIGMA INVESTMENTS, LP	13F Company 13F	0.93%	$7,199 15,436 shares	—	30 Sep 2024
TWO SIGMA SECURITIES, LLC	13F Company 13F	0.83%	$6,407 13,738 shares	—	30 Sep 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,607,038

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %